FDA Moves Ahead With Third-Party 510(k) Review
A new guidance document from the US FDA discusses how the agency will accredit and oversee third-party reviewers, as well as how it will determine which 510(k) devices are eligible for outside review.
You may also be interested in...
Lifting The Hood On MDUFA V
The document includes promises from the US FDA related to review timelines, consensus standards, the Total Product Life Cycle pilot, and more.
Third-Party Review: FDA Seeks Tangible 510(k) Results Over Next Three Years
Under a new plan and draft guidance issued by US FDA, the agency is hoping to streamline and improve its third-party review program. The goal is to spend substantially less FDA resources re-reviewing low-to-moderate risk 510(k) applications that go through the program and allow products to enter market sooner.
COVID-19 EUAs To Stay Active After Public Health Emergency Ends
Authorizations in place for diagnostics, personal protective equipment, and other products cleared for emergency use during the pandemic will remain in place until the potential for an outbreak no longer exists or products receive traditional clearances, according to a Federal Register notice issued by HHS this week.